Product Program year 2023 Source: CMS Open Payments

Coagadex

Drug Bleeding disorders

NDC 64208-7752-1

Open in the dashboard

General payments

$67,166

973 payments

Research payments

$0

0 payments

Through program year 2023, $67,166 in general payments and $0 in research payments were reported against Coagadex (Bleeding disorders).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2023 General $63,572 880
2022 General $3,594 93

Breakdown

Who paid General payments · program years 2022–2023
  1. Bio Products Laboratory USA, Inc. $67,166 973 payments
Top recipients General payments · program year 2023
  1. Brian Branchford Pediatric Hematology-Oncology · Milwaukee, WI $11,222 18% · 5 payments
  2. Terry Gernsheimer Hematology · Seattle, WA $5,500 9% · 1 payment
  3. Aneel Ashrani Hematology · Rochester, MN $5,250 8% · 8 payments
  4. Anita Dsouza Hematology & Oncology · Milwaukee, WI $5,054 8% · 8 payments
  5. Sascha Tuchman Hematology · Durham, NC $5,049 8% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Hematology Internal Medicine $15,828 25% · 4 practitioners
  2. Pediatric Hematology-Oncology Pediatrics $11,606 18% · 11 practitioners
  3. Hematology & Oncology Internal Medicine $10,144 16% · 8 practitioners
  4. Allergy Allergy & Immunology $5,486 9% · 35 practitioners
  5. Neurology Psychiatry & Neurology $5,309 8% · 61 practitioners

The top 5 of 43 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Wisconsin $16,427 26% · 11 recipients
  2. Washington $5,960 9% · 11 recipients
  3. Minnesota $5,290 8% · 3 recipients
  4. Oregon $5,173 8% · 7 recipients
  5. Texas $5,150 8% · 18 recipients

The top 5 of 38 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

973 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record